Does TOCILIZUMAB Cause Gait inability? 2,139 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,139 reports of Gait inability have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 2.2% of all adverse event reports for TOCILIZUMAB.
2,139
Reports of Gait inability with TOCILIZUMAB
2.2%
of all TOCILIZUMAB reports
1,203
Deaths
1,282
Hospitalizations
How Dangerous Is Gait inability From TOCILIZUMAB?
Of the 2,139 reports, 1,203 (56.2%) resulted in death, 1,282 (59.9%) required hospitalization, and 1,114 (52.1%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 2,139 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
INFLIXIMAB (1,824)
Which TOCILIZUMAB Alternatives Have Lower Gait inability Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE